Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers

被引:2
|
作者
Vu, Trung [1 ]
Fowler, Annaliese [2 ]
McCarty, Nami [2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis IMM, Ctr Stem Cell & Regenerat Dis, Houston, TX 77030 USA
[2] Texas A&M Univ, Dept Biomed Engn, Houston, TX 77030 USA
关键词
TP53; liver cancer; TRIM family; cell cycle; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; GENE-EXPRESSION; P53; MICRORNAS; SURVIVAL; PROMOTES; MIR-34A;
D O I
10.3390/cancers15153792
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The p53 protein is an important tumor suppressor, and TP53 mutations are frequently low survival rates of cancer patients. Mutations in TP53 lead in loss of tumor suppressing functions which result in the development of tumors. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the relationship between TRIM family genes and TP53 mutations in cancer remains unknown. In this study, we analyzed the links between TP53 mutations and TRIM family proteins and evaluated the role of TRIM family proteins in cancer patients with TP53 mutation. Our findings identified the TRIM family members that are highly expressed in TP53 mutant tumors and important for the cell growth in the context of TP53 mutations. The p53 protein is an important tumor suppressor, and TP53 mutations are frequently associated with poor prognosis in various cancers. Mutations in TP53 result in a loss of p53 function and enhanced expression of cell cycle genes, contributing to the development and progression of cancer. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the prognostic values between TP53 and TRIM family genes in cancer are unknown. In this study, we analyzed the relationship between the TP53 mutations and TRIM family proteins and evaluated the prognostic significance of TRIM family proteins in cancer patients with P53 mutations. Our findings identified specific TRIM family members that are upregulated in TP53 mutant tumors and are associated with the activation of genes related to a cell-cycle progression in the context of TP53 mutations.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal
    Govindan, Ramaswamy
    Weber, Jason
    CLINICAL CANCER RESEARCH, 2014, 20 (17) : 4419 - 4421
  • [42] Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
    Loeb, Keith R.
    Asgari, Maryam M.
    Hawes, Stephen E.
    Feng, Qinghua
    Stern, Joshua E.
    Jiang, Mingjun
    Argenyi, Zsolt B.
    de Villiers, Ethel-Michele
    Kiviat, Nancy B.
    PLOS ONE, 2012, 7 (04):
  • [43] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969
  • [44] The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
    Garrido-Navas, M. Carmen
    Garcia-Diaz, Abel
    Molina-Vallejo, Maria Pilar
    Gonzalez-Martinez, Coral
    Alcaide Lucena, Miriam
    Canas-Garcia, Ines
    Bayarri, Clara
    Delgado, Juan Ramon
    Gonzalez, Encarna
    Lorente, Jose Antonio
    Serrano, M. Jose
    CANCERS, 2020, 12 (11) : 1 - 17
  • [45] Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers
    Seagle, Brandon-Luke L.
    Eng, Kevin H.
    Dandapani, Monica
    Yeh, Judy Y.
    Odunsi, Kunle
    Shahabi, Shohreh
    ONCOTARGET, 2015, 6 (21) : 18641 - 18652
  • [46] TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
    Petitjean, A.
    Achatz, M. I. W.
    Borresen-Dale, A. L.
    Hainaut, P.
    Olivier, M.
    ONCOGENE, 2007, 26 (15) : 2157 - 2165
  • [47] Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
    Luo, Yanli
    Huang, Wentao
    Zhang, Huizhen
    Liu, Guang
    ONCOLOGY LETTERS, 2018, 15 (05) : 6161 - 6170
  • [48] TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
    A Petitjean
    M I W Achatz
    A L Borresen-Dale
    P Hainaut
    M Olivier
    Oncogene, 2007, 26 : 2157 - 2165
  • [49] TP53 mutations in head and neck cancer
    Nathan, Cherie-Ann
    Khandelwal, Alok R.
    Wolf, Gregory T.
    Rodrigo, Juan P.
    Makitie, Antti A.
    Saba, Nabil F.
    Forastiere, Arlene A.
    Bradford, Carol R.
    Ferlito, Alfio
    MOLECULAR CARCINOGENESIS, 2022, 61 (04) : 385 - 391
  • [50] TP53 Mutations in Canine Brain Tumors
    York, D.
    Higgins, R. J.
    LeCouteur, R. A.
    Wolfe, A. N.
    Grahn, R.
    Olby, N.
    Campbell, M.
    Dickinson, P. J.
    VETERINARY PATHOLOGY, 2012, 49 (05) : 796 - 801